Cytosorbents Corp (CTSO) dividend history

CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 2/30

$4.87−0.50 (-9.31%)

Close on Nov 13, 2026Market cap $306.04MP/E –Yield –

Dividends

No dividend per share appears in Cytosorbents's annual filings since fiscal 2010.

Parsed from the XBRL in Cytosorbents's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Sep 8, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CTSO.

Revenue growth3.1% · median 26.4%

Gross margin71.6% · median 61.4%

Operating margin-34.7% · median -1.3%

Net margin-48.9% · median -40.6%

Advertisement
300 × 250

See a number that looks wrong?